Deeper investigations on this, especially with a focus on the dysferlin’s partner proteins, with comprehensive functional analyses will likely identify modifiers of dysferlinopathies and their precise modifying role to explain the clinical heterogeneity of dysferlinopathies. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.